Enanta Pharmaceuticals Inc (ENTA)
12.92
-0.23
(-1.75%)
USD |
NASDAQ |
Apr 24, 16:00
12.91
-0.01
(-0.08%)
After-Hours: 20:00
Enanta Pharmaceuticals Market Cap: 273.34M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 273.34M |
| April 23, 2024 | 278.20M |
| April 22, 2024 | 284.34M |
| April 19, 2024 | 281.80M |
| April 18, 2024 | 279.89M |
| April 17, 2024 | 296.18M |
| April 16, 2024 | 324.96M |
| April 15, 2024 | 341.67M |
| April 12, 2024 | 348.02M |
| April 11, 2024 | 354.36M |
| April 10, 2024 | 349.92M |
| April 09, 2024 | 355.84M |
| April 08, 2024 | 346.11M |
| April 05, 2024 | 349.29M |
| April 04, 2024 | 342.30M |
| April 03, 2024 | 353.52M |
| April 02, 2024 | 345.90M |
| April 01, 2024 | 360.08M |
| March 28, 2024 | 369.38M |
| March 27, 2024 | 349.71M |
| March 26, 2024 | 337.44M |
| March 25, 2024 | 294.91M |
| March 22, 2024 | 308.67M |
| March 21, 2024 | 309.51M |
| March 20, 2024 | 306.76M |
| Date | Value |
|---|---|
| March 19, 2024 | 297.03M |
| March 18, 2024 | 285.82M |
| March 15, 2024 | 300.63M |
| March 14, 2024 | 293.22M |
| March 13, 2024 | 305.49M |
| March 12, 2024 | 307.61M |
| March 11, 2024 | 319.03M |
| March 08, 2024 | 325.80M |
| March 07, 2024 | 332.57M |
| March 06, 2024 | 331.30M |
| March 05, 2024 | 318.61M |
| March 04, 2024 | 331.09M |
| March 01, 2024 | 324.74M |
| February 29, 2024 | 304.01M |
| February 28, 2024 | 302.53M |
| February 27, 2024 | 297.24M |
| February 26, 2024 | 297.03M |
| February 23, 2024 | 284.76M |
| February 22, 2024 | 264.66M |
| February 21, 2024 | 274.60M |
| February 20, 2024 | 270.59M |
| February 16, 2024 | 274.82M |
| February 15, 2024 | 280.53M |
| February 14, 2024 | 279.47M |
| February 13, 2024 | 260.43M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
172.26M
Minimum
Nov 13 2023
1.979B
Maximum
Nov 05 2021
983.98M
Average
1.007B
Median
Mar 23 2021
Market Cap Benchmarks
| Madrigal Pharmaceuticals Inc | 4.072B |
| Galectin Therapeutics Inc | 203.66M |
| Viking Therapeutics Inc | 6.539B |
| Akero Therapeutics Inc | 1.397B |
| 89bio Inc | 817.03M |
Market Cap Related Metrics
| PS Ratio | 3.696 |
| PEG Ratio | -0.1549 |
| Price to Book Value | 1.424 |
| Price | 12.92 |
| Earnings Yield | -50.77% |
| PEGY Ratio | -0.1549 |